[Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
D000679:Amygdala / Q000503:physiopathology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002421:Caudate Nucleus / Q000503:physiopathology; D003342:Corpus Striatum / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D006801:Humans; D008032:Limbic System / Q000503:physiopathology*; D009833:Olfactory Pathways / Q000503:physiopathology; D011956:Receptors, Cell Surface / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012688:Septum Pellucidum / Q000503:physiopathology
D014150:Antipsychotic Agents; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin; D004298:Dopamine
O vozmozhnom uchastii limbicheskikh struktur perednego mozga v mekhanizme antipsikhoticheskogo deĭstviia neĭrolepticheskikh preparatov pri shizofrenii (obzor).